Significant differences can be seen between the two subgroups in treatment exposure (hepatic resection vs. others), in tumor size (< 5 cm vs. ≥ 5 cm), in TNM stage (I, II vs. III, IV), in serum AFP level (< 400 ng / mL vs. ≥ 400 ng / mL), in serum CRP level (< 6.7 mg / L vs. ≥ 6.7 mg / L), in serum albumin level (< 40 g / L vs. ≥ 40 g / L), and in platelet / CRP (< 47.8 vs. ≥ 47.8). Here, AFP is linked to neoplasm.